What’s new at PolyPeptide? Things are happening all the time!
If you need more information about our company, you can request our brochures here


Information Letter on COVID-19

Download letter PDF here


Dear Valued Customer,

As concern regarding the impact of the worldwide Covid-19 outbreak continues to grow, we want to assure you that the PolyPeptide Group remains committed to fulfilling your requirements for life-saving and life-changing APIs.

Since the health and safety of our employees remains the top priority, all PolyPeptide sites have taken a prudent and proactive approach to the situation. All locations are practicing rigorous cleaning and infection control procedures.  In addition, flexible, staggered schedules, smaller teams and work from home options have enabled all sites to operate with fewer people on site at any given time, reducing potential contact amongst employees while maintaining operations at a close-to-normal pace.

We are also restricting visitors to our sites and have implemented a travel ban for all employees until recommendations and directives from National and Local Governmental Agencies are revised.  In the meantime, we invite you to take advantage of our secure videoconferencing system allowing ”face to face” discussions with your project team at any time.

To date we have been very fortunate to have only minor changes to our plans and projects.  The vast majority of our activities remain fully on schedule and we will continue to track these closely, as the situation continues.  While we cannot promise that the impact of the Covid-19 pandemic will remain small, we can promise we will do everything in our power to meet your project timeline. We will continue to track all projects closely and alert you immediately of any changes to the delivery schedule for your product or project.

This isn’t business as usual, and we are all re-evaluating conditions every day. Let’s keep the lines of communication open as we work to support your projects, your business, and your patients.

Thank you for your ongoing partnership and support during this challenging time.

Wishing you and your family good health,

Kind regards,




Jane Salik, CEO

Download letter PDF here


MVA Medicona Valley Alliance

New member of the Medicon Valley Alliance

We are happy to inform that the PolyPeptide Group is from now a member of the Medicon Valley Alliance (MVA). It is a non-profit membership organization, the leading life science cluster in Scandinavia and one of the largest in Europe. With this membership, we wish to strengthen our presence, support and knowledge sharing in the region as the global leader in Peptide Development and Manufacturing.


PolyPeptide News Flash February 2020


In 2019 we made significant progress in reducing solvent consumption. Our goal is to become the greenest solution provider for peptides, learn more in our February Newsletter.



Innovation & Technology

Innovation and Technology

Innovation is considered as a key driver for the future of our business. In 2020 we will highlight our focus and progress on Innovation and Technology even more. Why is Innovation so important? Learn more in this new video. 



PolyPeptide News Flash October

Find out the latest news in our October Newsletter



Press release: the start of a research collaboration program with IBMM in Montpellier, France

PolyPeptide Group is pleased to announce the start of a research collaboration program with the Green Chemistry and Enabling Technologies Team of IBMM (Institut des Biomolécules Max Mousseron) in Montpellier. Read complete press release research_collaboration_program_IBMM_PolyPeptide



Symposium on Preparative and Process Scale HPLC, MCC and SFC 2019

PolyPeptide Group will be present at the Symposium on Preparative & Process Scale HPLC, MCC and SFC 2019 
on September 10-11 in Gothenburg, Sweden, to discuss the latest trends in preparative and process chromatography
among scientists and engineers from all over the world. Per Möller, Process Development, PolyPeptide Group, is one of
the speakers presenting “Strategies and Practical Considerations in the Downstream Process Development of Synthetic Peptides".
Read more​​


Book your meeting with PolyPeptide at CPhI worldwide - Frankfurt, Germany 5-7 November 2019

Meet PolyPeptide Group 5-7 November in Frankfurt, Germany. Contact your Sales Representative or send us an email: to schedule a meeting.
We look forward to seeing you at booth 42F12.
Find out more about CPhI worldwide Europe


100% Sustainable energy from wind turbines at PolyPeptide Sweden

Polypeptide Laboratories (Sweden) AB reduces Carbon dioxide emissions with 2206 ton in 2019 when 100% of the electricity comes from wind power. PolyPeptide Group focuses on finding sustainable solutions, all ways, always.

See certification from E.ON (in swedish only)


PolyPeptide attends TIDES Europe - Amsterdam, November 7th and 8th

PolyPeptide attends TIDES Europe in Amsterdam, Postillion Convention Center, November 7th and 8th. Contact us: to set a meeting or come by our booth #13.

Want to learn more about “Successful Characterization of Peptide APIs & Setting the Specifications Optimally”? Join the presentation Thursday, November 8th, 12:40 - 13:10 with Didier Monnaie, Head of Analytical Department, PolyPeptide Group. Read more here


Looking forward to seeing you at CPhI Madrid, 9-11 October, Hall 8, stand #8B2

Contact your PolyPeptide Sales Representative to schedule a meeting or send an email to:


Sign up for PolyPeptide’s Newsletter